The Bronchoconstrictive Action of Evodiamine, an Indoloquinazoline Alkaloid Isolated from the Fruits of Evodia rutaecarpa, on Guinea-Pig Isolated Bronchus: Possible Involvement on Vanilloid Receptors

Abstract

Evodiamine, a constituent of Evodiae Fructus (Evodia rutaecarpa Benth., Rutaceae), produced a bronchial contraction that is resistant to atropine and abolished by pretreatment with a mixture of the NK₁ and NK₂ receptor antagonists. Contractile responses to evodiamine were examined in guinea-pig isolated bronchus and compared with those to capsaicin. Both compounds evoked bronchial contraction in a concentration-dependent manner. Maximal contractions for evodiamine and capsaicin were observed at concentrations of 3 μM and 1 μM, respectively. Capsazepine (10 μM), an established antagonist of vanilloid receptor (capsaicin receptor), competitively inhibited the bronchial contraction evoked by evodiamine, suggesting that evodiamine activated vanilloid receptors. Evodiamine (3 μM) and capsaicin (1 μM) produced complete crossed tachyphylaxis. Both compounds desensitized tissues to subsequent additions of either evodiamine or capsaicin. These results suggest that the evodiamine-induced contractile response of the bronchus could be attributed to the resultant tachykinin release from sensory neurons by binding of evodiamine to vanilloid receptors. Rutaecarpine, which belongs to the same indoloquinazoline-type alkaloid as evodiamine, showed neither bronchoconstrictive, desensitizing effects nor vanilloid antagonistic effects at all the concentrations examined (up to 200 μM).

Key words

Evodia rutaecarpa - Rutaceae - evodiamine - rutaecarpine - capsaicin - guinea-pig isolated bronchus - vanilloid receptor

References

• 1 Barnes  P J.. Asthma as an axon reflex.  Lancet. 1986;;  1 242-5
• 2 Grundström  N,, Anderson  R GG,, Wikberg  J ES.. Pharmacological characterization of the autonomous innervation of the guinea pig tracheo-bronchial smooth muscle.  Acta Pharmacol. Toxicol.. 1981;;  49 150-7
• 3 Renzetti  L M,, Shenvi  A,, Buckner  C K.. Nonadrenergic, noncholinergic contractile responses of the guinea pig hilar bronchus involve the preferential activation of tachykinin neurokinin2 receptors.  J. Pharmacol. Exp. Ther.. 1992;;  262 957-63
• 4 Ikemura  T,, Okamura  K,, Sasaki  Y,, Ishii  H,, Ohmori  K.. KW-4679-induced inhibition of tachykininergic contraction of peripheral sensory nerves.  Br. J. Pharmacol.. 1996;;  117 967-73
• 5 Szolcsányi  J.. Tetrodotoxin-resistant non-cholinergic neurogenic contraction evoked by capsaicinoids and piperine on the guinea-pig trachea.  Neurosci. Lett.. 1983;;  42 83-8
• 6 Caterina  M J,, Schumacher  M A,, Tominaga  M,, Rosen  T A,, Levine  J D,, Julius  D.. The capsaicin receptor: a heat-activated ion channel in the pain pathway.  Nature. 1997;;  389 816-24
• 7 Tominaga  M,, Caterina  M J,, Malmberg  A B,, Rosen  T A,, Gilbert  H,, Skinner  K et al.. The cloned capsaicin receptor integrates multiple pain-producing stimuli.  Neuron. 1998;;  21 531-43
• 8 Walpole  C SJ,, Wrigglesworth  R,, Bevan  S,, Campbell  E A,, Dray  A,, James  I F et al.. Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 1. The aromatic “A-region”.  J. Med. Chem.. 1993;;  36 2362-72
• 9 Walpole  C SJ,, Wrigglesworth  R,, Bevan  S,, Campbell  E A,, Dray  A,, James  I F et al.. Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 2. The amide bond “B-region”.  J. Med. Chem.. 1993;;  36 2373-80
• 10 Walpole  C J,, Wrigglesworth  R,, Bevan  S,, Campbell  E A,, Dray  A,, James  I F et al.. Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 3. The hydrophobic side-chain “C-region”.  J. Med. Chem.. 1993;;  36 2381-9
• 11 Virus  R M,, Gebhart  G F.. Pharmacologic actions of capasacin: apparent involvement of substance P and serotonin.  Life Sci.. 1979;;  25 1273-83
• 12 Brand  L M,, Skare  K L,, Loomans  M E,, Reller  H H,, Schwen  R J,, Lade  Da et al.. Ant-inflammatory pharmacology and mechanism of the orally active capsaicin analogues, NE-19550 and NE-28345.  Agents & Actions. 1990;;  31 329-40
• 13 Yeh  J L,, Lo  Y C,, Wang  Y,, Chang  I J.. Cardiovascular interactions of nonivamide, glyceryl nonivamide, capsaicin analogues, and substance P antagonist in rats.  Brain Res. Bull.. 1993;;  30 641-8
• 14 Szallasi  A,, Blumberg  P M.. Vanilloid receptors: new insights enhance potential as a therapeutic target.  Pain. 1996;;  68 195-208
• 15 de Vries  D J,, Blumberg  P M.. Thermoregulatory effects of resiniferatoxin in the mouse: comparison with capsaicin.  Life Sci.. 1989;;  44 711-5
• 16 Szallasi  A,, Blumberg  P M.. Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper.  Neuroscience. 1989;;  30 515-20
• 17 Walpole  C SJ,, Bevan  S,, Bovermann  G,, Boelsterli  J J,, Breckenridge  R,, Davis  J W et al.. The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin.  J. Med. Chem.. 1994;;  37 1942-54
• 18 Klopman  G,, Li  J Y.. Quantitative structure-agonist activity relationship of capsaicin analogues.  J. of Computer-Aided Molecular Design. 1995;;  9 283-94
• 19 Walpole  C SJ,, Bevan  S,, Broomfield  G,, Breckenridge  R,, James  I F,, Ritchie  T et al.. The similarities and differences in the structure-activity relationships of capsaicin and resiniferatoxin analogues.  J. Med. Chem.. 1996;;  39 2939-52
• 20 Patacchini  R,, Maggi  A C,, Meli  A.. Capsaicin-like activity of some natural pungent substances on peripheral endings of visceral primary afferents.  Naunyn-Schmiedeberg's Arch. Pharmacol.. 1990;;  342 72-7